Overview

LC526 (Lipo-MIC) is a multi-component metabolic research formulation studied in laboratory settings for its role in mitochondrial bioenergetics, fatty acid transport, hepatic lipid processing, and one-carbon metabolism. What distinguishes LC526 from other lipotropic research tools is its dual coverage of two connected stages of mitochondrial energy metabolism: the upstream fatty acid transport machinery driven by L-Carnitine and the CPT system, and the downstream electron transport chain dynamics governed by the NADH/NAD⁺ ratio. This pairing makes the formulation particularly suited to multi-pathway mitochondrial research within a single experimental system.

Within biological systems, the constituents of LC526 contribute to several interconnected biochemical pathways. L-Carnitine participates in shuttling long-chain fatty acids into the mitochondria, NADH functions as a central electron carrier in oxidative phosphorylation, and the MIC complex — Methionine, Inositol, and Choline — supports the methyl-donor dynamics and phospholipid pathways studied in hepatic lipid metabolism. Vitamin B12 and high-dose Vitamin B6 round out the blend as cofactors examined in methylation and amino acid transamination research. Together, these overlapping functions make LC526 a relevant compound in experimental models investigating energy balance, lipid export, and metabolic regulation.

Supplied at 526mg per vial and intended strictly for scientific, analytical, and in-vitro laboratory research use, LC526 carries batch and lot identifiers on all labeling for full documentation compliance.

Research Background

Each component of the LC526 blend is supported by an established biochemistry research literature spanning several decades.

L-Carnitine's role in the carnitine palmitoyltransferase (CPT) mitochondrial fatty acid transport system was characterized in the foundational work of Fritz and Yue (1963), and it remains a frequently studied agent in fatty acid oxidation and energy metabolism research. NADH, the reduced electron-carrier form of NAD⁺, has been investigated as a mitochondrial electron carrier since the work of Warburg and Christian in the 1930s; its inclusion alongside L-Carnitine allows researchers to examine both the transport and electron-transfer dimensions of mitochondrial respiration in parallel.

The MIC lipotropic components — Methionine, Inositol, and Choline — have been studied for decades in hepatic lipid metabolism research, particularly in relation to phospholipid synthesis, VLDL assembly, methyl-donor dynamics, and lipid export pathways in laboratory models. Vitamin B12 was established as a methionine synthase cofactor in the 1950s following its isolation by Rickes et al., linking the formulation to one-carbon metabolism and methylation cycle research. High-dose Vitamin B6 contributes to studies of amino acid transamination and methylation pathway activity.

Due to its characterized, multi-component composition and broad relevance across fatty acid transport, electron transport chain, and methylation pathways, LC526 continues to serve as a useful tool in preclinical mitochondrial bioenergetics and lipid metabolism research. All information provided here is for educational and reference purposes only and does not constitute medical or clinical guidance.

Common Research Focus Areas

• Mitochondrial bioenergetics and respiratory chain dynamics (NADH/NAD⁺ ratio studies)

• Carnitine-mediated fatty acid transport and beta-oxidation research

• Hepatic lipid metabolism, phospholipid synthesis, and VLDL assembly studies

• Methyl-donor dynamics and one-carbon metabolism investigations (MIC complex)

• Methionine synthase cofactor activity and methylation pathway research

• Amino acid transamination and energy metabolism pathway investigation